Corbevax Vaccine – Shot registration for 5-12 Years Old Approved

Rate this post

India has been working hard to increase vaccination coverage among children and adults. Earlier this month, it was determined that booster dosages were safe for all individuals. It is important to note that in many regions of the nation, schools’ physical courses have restarted due to the most recent round of approvals. In the previous several weeks, many schools in Delhi and surrounding areas have reported virus outbreaks. Read the article to know about Corbevax Vaccine – Shot registration for 5-12 Years Old Approved.

Corbevax Vaccine

Three Covid-19 vaccines received regulatory clearance from the Drugs Controller General of India (DCGI) on Tuesday, according to sources in the Indian health ministry. An emergency use authorization (EUA) for Bharat Biotech’s Covaxin for children aged 6-12 years and for Biological E’s Corbevax for children aged 5-12 years has been issued by the Indian drug regulatory authority, according to sources.

Corbevax Vaccine

Additionally, on Tuesday, the Covid-19 vaccine, a two-dose regimen developed by Gujarat-based Zydus Cadila, was awarded emergency use authorization for the 12 years and older group. The three-dose form of the DNA vaccine developed by Zydus Cadila is being utilized in the country’s national vaccination campaign for the general adult population. It is the first Covid-19 vaccine to be constructed on a DNA platform and has been licensed for use in the pharmaceutical industry.

Corbevax Vaccine Shot Registration

Several members of the Goa government’s expert group on Covid-19 have predicted that the coastal state might be affected by a probable fourth wave of the epidemic in June or July. According to the Press Trust of India, Dr. Shivanand Bandekar, the committee chairman, has said that the experts have advised against decreasing the guard on Covid-19.

Bandekar has recommended that people keep their masks on when in public locations to prevent the sickness from spreading further. PTI reports that committee members have evaluated preparations for another coronavirus outbreak. The state has a sufficient supply of medications to cope with any crisis.

On December 25, less than a year after India launched one of the world’s most extensive adult Covid-19 vaccination campaigns, Prime Minister Narendra Modi declared that children between 15 and 18 would also be vaccinated. As a consequence of an increase in occurrences of the highly contagious Omicron form in different parts of the country and the reopening of schools and institutions in stages, the decision was made.

Children in the 12-14 age group were eligible to get their Covid-19 vaccination starting on March 27 as the Centre opted to broaden its vaccination push.

Corbevax Vaccine for 5-12 Years Old Approved

Covaxin is one of the two primary vaccines currently being given in India, the other being Covishield, which the Serum Institute of India manufactures. Corbevax, a Covid-19 vaccine created by Hyderabad-based Biological E, was granted emergency use authorization by India’s medicines authority in February for youngsters between 12 and 18 years.

In January of last year, India launched the world’s most extensive vaccination campaign against Covid, targeting all individuals on the frontlines of the battle against the epidemic. Two months later, the coverage was extended to individuals over the age of 60, and it was extended to all adults in May of 2021. The vaccination campaign for 15-18-year-olds began in January and was subsequently extended to include different age groups.

In response to growing concerns about variations, booster doses are increasingly being offered to adults. According to a statement from the Health Ministry, “187.95 billion vaccine doses have been delivered thus far under the Nationwide Vaccination Drive.”

While the number of Covid cases in the nation has risen to more than 2,000, the country’s situation is under control compared to China and certain European countries, where the increase has been concerning since March.